Clinigen Group

Clinigen Group is a specialized pharmaceutical services company that bridges critical gaps in global medicine access. Its business model is built on three synergistic pillars: Clinical Trial Services (CTS), supplying drugs for research; Unlicensed Medicines (Managed Access), providing pre-approval drugs to patients; and Commercial Medicines (AP), marketing and distributing niche, often hospital-based, products. As a publicly traded company, it has established itself as a key partner for pharma and biotech firms seeking to optimize the lifecycle of their products from development through to commercialization in complex markets. Its strategy focuses on integrating these services to create a unique, full-service offering for its clients.

Integrated global regulatory, logistics, and quality management service platform for clinical trial supply, managed access programs, and commercial distribution of pharmaceuticals.

Clinigen competes with large Clinical Research Organizations (CROs) like IQVIA and Parexel in trial supply, with specialty distributors in commercial medicines, and with other dedicated managed access providers. Its differentiated, integrated three-pillar model is its primary competitive advantage, though larger players are expanding into these adjacent service areas.